NCT06815913

Brief Summary

This is a retrospective observational study using the methodology of creating medical registries. The expected number of patients included in the registry is about 2000 patients with myocardial infarction and/or ACVD of any duration and concomitant non-cardiac diseases of therapeutic profile in pilot healthcare organizations for any reason during 2019-2022 based on the source medical records data.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
0mo left

Started Mar 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Mar 2024Jun 2026

Study Start

First participant enrolled

March 1, 2024

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 10, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

February 10, 2025

Status Verified

February 1, 2025

Enrollment Period

1.8 years

First QC Date

February 4, 2025

Last Update Submit

February 4, 2025

Conditions

Keywords

registrymultimorbiditychronic non-communicable diseasescardiovascular diseasesmyocardial infarctionacute cerebrovascular disease

Outcome Measures

Primary Outcomes (1)

  • Mortality from other causes

    number of deaths from other diseases

    3 years

Other Outcomes (6)

  • Time to combined end point

    3 years

  • Proportion of patients with non-fatal myocardial infarction

    3 years

  • Proportion of patients with non-fatal cerebral stroke

    3 years

  • +3 more other outcomes

Study Arms (2)

myocardial infarction

Some patients with non-fatal myocardial infarction

acute cerebrovascular disease

Hospitalization due to cardiovascular diseases, some patients with hospitalization due to cardiovascular diseases

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who applied to the pilot ambulatory health care organizations between 2019-2022 in order to identify and "look for" patients after acute cardiovascular event, but who were not monitored for that event for various reasons (statute of limitations, refusal, relocation, etc.); meeting the inclusion criteria and not meeting the exclusion criteria.

You may qualify if:

  • All patients who applied to the pilot ambulatory health care organizations between 2019-2022 in order to identify and "look for" patients after acute cardiovascular event, but who were not monitored for that event for various reasons (statute of limitations, refusal, relocation, etc.);
  • All patients discharged from hospitals with a final diagnosis of AMI/ACVD, assigned territorially to the pilot polyclinics in the period 2019-2022.
  • Presence of a history of AMI and/or ACVD;
  • Age 18 years and older.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Republican Scientific and Practical Center of Cardiology

Minsk, 220036, Belarus

Location

MeSH Terms

Conditions

Myocardial InfarctionNoncommunicable DiseasesCardiovascular Diseases

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisDisease Attributes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Laboratories of Comorbid Cardiology, RSPC Cardiology, Ph.D (Medicine)

Study Record Dates

First Submitted

February 4, 2025

First Posted

February 10, 2025

Study Start

March 1, 2024

Primary Completion

December 31, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

February 10, 2025

Record last verified: 2025-02

Locations